{{item.videoDuration}}
{{item.title}}
{{item.text}}
{{item.videoDuration}}
{{item.title}}
{{item.text}}
The environment in which pharmaceutical and life sciences companies operate is increasingly challenging, being driven by a more and more demanding healthcare agenda mainly due to regulation, increased competition and changing customer needs.
Specifically in Greece and as a result of the recent sovereign crisis, pharmaceutical companies are facing numerous challenges which could be combined under four main categories:
- pressure on margins and profitability
- funding and liquidity constraints
- risk and compliance
- planning and forecasting
These challenges have a significant impact on pharmaceutical companies’ business models, making the industry in Greece even more dynamic.
Working closely with our clients, ranging from small entrepreneurial pharmaceutical companies to large global corporations in Greece, we aim at helping them to evaluate their strategic business options, providing audit, advisory and tax services that specifically tackle the challenges of the sector and add value across the companies’ value chain.
{{filterContent.facetedTitle}}
{{contentList.dataService.numberHits}} {{contentList.dataService.numberHits == 1 ? 'result' : 'results'}}
{{contentList.loadingText}}
{{contentList.loadingText}}
Contact us
Follow us
